Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.
 https://image.nostr.build/8cfdc9123b87ac33d5742bc6d5706f6849dc9a20100c6f92d92a32d540949a43.jpg 
The experimental device, known as Blindsight, "will enable even those who have lost both eyes and their optic nerve to see," Musk said, opens new tab in a post on X.